229 related articles for article (PubMed ID: 30884334)
1. Effects of acute N-acetylcysteine challenge on cortical glutathione and glutamate in schizophrenia: A pilot in vivo proton magnetic resonance spectroscopy study.
Girgis RR; Baker S; Mao X; Gil R; Javitt DC; Kantrowitz JT; Gu M; Spielman DM; Ojeil N; Xu X; Abi-Dargham A; Shungu DC; Kegeles LS
Psychiatry Res; 2019 May; 275():78-85. PubMed ID: 30884334
[TBL] [Abstract][Full Text] [Related]
2. Effects of N-acetylcysteine on brain glutamate levels and resting perfusion in schizophrenia.
McQueen G; Lally J; Collier T; Zelaya F; Lythgoe DJ; Barker GJ; Stone JM; McGuire P; MacCabe JH; Egerton A
Psychopharmacology (Berl); 2018 Oct; 235(10):3045-3054. PubMed ID: 30141055
[TBL] [Abstract][Full Text] [Related]
3. Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study.
Iwata Y; Nakajima S; Plitman E; Caravaggio F; Kim J; Shah P; Mar W; Chavez S; De Luca V; Mimura M; Remington G; Gerretsen P; Graff-Guerrero A
Biol Psychiatry; 2019 Apr; 85(7):596-605. PubMed ID: 30389132
[TBL] [Abstract][Full Text] [Related]
4. Effect of single dose N-acetylcysteine administration on resting state functional connectivity in schizophrenia.
McQueen G; Lay A; Lally J; Gabay AS; Collier T; Lythgoe DJ; Barker GJ; Stone JM; McGuire P; MacCabe JH; Egerton A
Psychopharmacology (Berl); 2020 Feb; 237(2):443-451. PubMed ID: 31786651
[TBL] [Abstract][Full Text] [Related]
5. N-acetylcysteine normalizes glutamate levels in cocaine-dependent patients: a randomized crossover magnetic resonance spectroscopy study.
Schmaal L; Veltman DJ; Nederveen A; van den Brink W; Goudriaan AE
Neuropsychopharmacology; 2012 Aug; 37(9):2143-52. PubMed ID: 22549117
[TBL] [Abstract][Full Text] [Related]
6. Metabolite profiles in the anterior cingulate cortex of depressed patients differentiate those taking N-acetyl-cysteine versus placebo.
Das P; Tanious M; Fritz K; Dodd S; Dean OM; Berk M; Malhi GS
Aust N Z J Psychiatry; 2013 Apr; 47(4):347-54. PubMed ID: 23341476
[TBL] [Abstract][Full Text] [Related]
7. N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis.
Conus P; Seidman LJ; Fournier M; Xin L; Cleusix M; Baumann PS; Ferrari C; Cousins A; Alameda L; Gholam-Rezaee M; Golay P; Jenni R; Woo TW; Keshavan MS; Eap CB; Wojcik J; Cuenod M; Buclin T; Gruetter R; Do KQ
Schizophr Bull; 2018 Feb; 44(2):317-327. PubMed ID: 29462456
[TBL] [Abstract][Full Text] [Related]
8. N-acetylcysteine normalizes neurochemical changes in the glutathione-deficient schizophrenia mouse model during development.
das Neves Duarte JM; Kulak A; Gholam-Razaee MM; Cuenod M; Gruetter R; Do KQ
Biol Psychiatry; 2012 Jun; 71(11):1006-14. PubMed ID: 21945305
[TBL] [Abstract][Full Text] [Related]
9. Intra-Regional Glu-GABA vs Inter-Regional Glu-Glu Imbalance: A 1H-MRS Study of the Neurochemistry of Auditory Verbal Hallucinations in Schizophrenia.
Hjelmervik H; Craven AR; Sinceviciute I; Johnsen E; Kompus K; Bless JJ; Kroken RA; Løberg EM; Ersland L; Grüner R; Hugdahl K
Schizophr Bull; 2020 Apr; 46(3):633-642. PubMed ID: 31626702
[TBL] [Abstract][Full Text] [Related]
10. Genetic Polymorphism Associated Prefrontal Glutathione and Its Coupling With Brain Glutamate and Peripheral Redox Status in Early Psychosis.
Xin L; Mekle R; Fournier M; Baumann PS; Ferrari C; Alameda L; Jenni R; Lu H; Schaller B; Cuenod M; Conus P; Gruetter R; Do KQ
Schizophr Bull; 2016 Sep; 42(5):1185-96. PubMed ID: 27069063
[TBL] [Abstract][Full Text] [Related]
11. Effects of repeated dizocilpine treatment on glutamatergic activity in the prefrontal cortex in an animal model of schizophrenia: An in vivo proton magnetic resonance spectroscopy study at 9.4T.
Yoo CH; Song KH; Lim SI; Lee DW; Woo DC; Choe BY
Neurosci Lett; 2017 Jan; 637():57-63. PubMed ID: 27894920
[TBL] [Abstract][Full Text] [Related]
12. Glutathione and glutamate in schizophrenia: a 7T MRS study.
Kumar J; Liddle EB; Fernandes CC; Palaniyappan L; Hall EL; Robson SE; Simmonite M; Fiesal J; Katshu MZ; Qureshi A; Skelton M; Christodoulou NG; Brookes MJ; Morris PG; Liddle PF
Mol Psychiatry; 2020 Apr; 25(4):873-882. PubMed ID: 29934548
[TBL] [Abstract][Full Text] [Related]
13. N-Acetylcysteine effects on glutathione and glutamate in schizophrenia: A preliminary MRS study.
Yang YS; Maddock RJ; Zhang H; Lee J; Hellemann G; Marder SR; Green MF
Psychiatry Res Neuroimaging; 2022 Sep; 325():111515. PubMed ID: 35839558
[TBL] [Abstract][Full Text] [Related]
14. Anterior Cingulate Glutamate and GABA Associations on Functional Connectivity in Schizophrenia.
Shukla DK; Wijtenburg SA; Chen H; Chiappelli JJ; Kochunov P; Hong LE; Rowland LM
Schizophr Bull; 2019 Apr; 45(3):647-658. PubMed ID: 29912445
[TBL] [Abstract][Full Text] [Related]
15. Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data.
Merritt K; McGuire PK; Egerton A; ; Aleman A; Block W; Bloemen OJN; Borgan F; Bustillo JR; Capizzano AA; Coughlin JM; De la Fuente-Sandoval C; Demjaha A; Dempster K; Do KQ; Du F; Falkai P; Galinska-Skok B; Gallinat J; Gasparovic C; Ginestet CE; Goto N; Graff-Guerrero A; Ho BC; Howes OD; Jauhar S; Jeon P; Kato T; Kaufmann CA; Kegeles LS; Keshavan M; Kim SY; Kunugi H; Lauriello J; Liemburg EJ; Mcilwain ME; Modinos G; Mouchlianitis ED; Nakamura J; Nenadic I; Öngür D; Ota M; Palaniyappan L; Pantelis C; Plitman E; Posporelis S; Purdon SE; Reichenbach JR; Renshaw PF; Russell BR; Sawa A; Schaefer M; Shungu DC; Smesny S; Stanley JA; Stone JM; Szulc A; Taylor R; Thakkar K; Théberge J; Tibbo PG; van Amelsvoort T; Walecki J; Williamson PC; Wood SJ; Xin L; Yamasue H
JAMA Psychiatry; 2021 Jun; 78(6):667-681. PubMed ID: 33881460
[TBL] [Abstract][Full Text] [Related]
16. Corticolimbic hyper-response to emotion and glutamatergic function in people with high schizotypy: a multimodal fMRI-MRS study.
Modinos G; McLaughlin A; Egerton A; McMullen K; Kumari V; Barker GJ; Keysers C; Williams SC
Transl Psychiatry; 2017 Apr; 7(4):e1083. PubMed ID: 28375210
[TBL] [Abstract][Full Text] [Related]
17. Imaging glutamate redistribution after acute N-acetylcysteine administration: A simultaneous PET/MR study.
O'Gorman Tuura R; Warnock G; Ametamey S; Treyer V; Noeske R; Buck A; Sommerauer M
Neuroimage; 2019 Jan; 184():826-833. PubMed ID: 30296554
[TBL] [Abstract][Full Text] [Related]
18. Glutamate metabolites in treatment resistant schizophrenia: A meta-analysis and systematic review of
Kumar V; Manchegowda S; Jacob A; Rao NP
Psychiatry Res Neuroimaging; 2020 Jun; 300():111080. PubMed ID: 32279055
[TBL] [Abstract][Full Text] [Related]
19. Decoupling of N-acetyl-aspartate and glutamate within the dorsolateral prefrontal cortex in schizophrenia.
Coughlin JM; Tanaka T; Marsman A; Wang H; Bonekamp S; Kim PK; Higgs C; Varvaris M; Edden RA; Pomper M; Schretlen D; Barker PB; Sawa A
Curr Mol Med; 2015; 15(2):176-83. PubMed ID: 25732147
[TBL] [Abstract][Full Text] [Related]
20. 7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia.
Reid MA; Salibi N; White DM; Gawne TJ; Denney TS; Lahti AC
Schizophr Bull; 2019 Jan; 45(1):180-189. PubMed ID: 29385594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
